Related Experiment Video

Updated: May 13, 2026

Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts
09:20

Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts

Published on: June 26, 2018

Anticancer activity of olive oil hydroxytyrosyl acetate in human adenocarcinoma Caco-2 cells

Raquel Mateos1, Gema Pereira-Caro, James R Bacon

  • 1Institute of Food Research, Norwich Research Park, Colney Lane, Norwich, UK. raquel.mateos@ictan.csic.es

Journal of Agricultural and Food Chemistry
|March 5, 2013
PubMed

Insights

Hydroxytyrosyl acetate (HTy-Ac) shows anticancer effects by inhibiting colon cancer cell proliferation and arresting the cell cycle. It also promotes apoptosis and enhances carcinogen detoxification, suggesting potential for colon cancer modulation.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Colon cancer remains a significant global health challenge.
  • Identifying novel therapeutic agents with multi-target effects is crucial.
  • Hydroxytyrosyl acetate (HTy-Ac) is a derivative of hydroxytyrosol, a phenolic compound with known bioactivity.

Purpose of the Study:

  • To investigate the anticancer activity of hydroxytyrosyl acetate (HTy-Ac) in human colon adenocarcinoma cells.
  • To evaluate the effects of HTy-Ac on genes involved in cell cycle regulation, apoptosis, and xenobiotic metabolism.
  • To explore the potential of HTy-Ac as a colon cancer therapeutic agent.

Main Methods:

  • Caco-2/TC7 cells were exposed to varying concentrations (5, 10, 50 μM) of HTy-Ac for 24 hours.
  • Gene expression analysis was performed using reverse transcription polymerase chain reaction (RT-PCR).
  • Evaluated genes included those related to cell cycle (p21, p53, cyclin B1, cyclin G2), apoptosis (BNIP3, BNIP3L, PDCD4, ATF3), and detoxification enzymes (CYP1A1, UGT1A10).

Main Results:

  • HTy-Ac inhibited cell proliferation and induced cell cycle arrest by up-regulating p21 and CCNG2, while down-regulating CCNB1.
  • The compound promoted apoptosis by up-regulating BNIP3, BNIP3L, PDCD4, and ATF3, and activating caspase-3.
  • HTy-Ac enhanced the expression of xenobiotic metabolizing enzymes CYP1A1 and UGT1A10, indicating improved carcinogen detoxification.

Conclusions:

  • Hydroxytyrosyl acetate (HTy-Ac) exhibits significant anticancer properties against colon adenocarcinoma cells.
  • HTy-Ac modulates key molecular pathways including cell cycle progression, apoptosis, and detoxification.
  • These findings suggest HTy-Ac holds potential as a therapeutic agent for colon cancer intervention.

More Related Videos

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration11:13

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration

Published on: June 9, 2023

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...